AMICUS THERAPEUTICS, INC. — Director's Dealing 2022

Jan 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2022-01-14

Reporting Person: Quimi Daphne (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-14	Common Stock	A	36840	—	Acquired	368746	Direct
2022-01-14	Common Stock	F	18843	$10.53	Disposed	349903	Direct

Footnotes

F1: Granted for the achievement of the 2019 PRSU TSR goal as determined by the Board of Directors.